Bio-Rad Laboratories BIO
NYSE BIO
$382.40 +3.37 (+0.89%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017)

Bio-Rad Laboratories' (BIO) quarterly Depreciation & Amortization (CF) came in at $35.4 million in Q3 2017, down 8.12% year-over-year from $38.5 million in Q3 2016, and down 4.49% quarter-over-quarter from $37.0 million in Q2 2017.

Analysis

Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $35.4 million the latest figure, recorded in Q3 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 66.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 102.04 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 24.14 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 19.06 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 9.66 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 58.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 35.36 Mn
Jun 30, 2017 37.03 Mn
Mar 31, 2017 33.66 Mn
Sep 30, 2016 38.49 Mn
Jun 30, 2016 37.58 Mn
Mar 31, 2016 34.09 Mn
Sep 30, 2015 33.56 Mn
Jun 30, 2015 32.13 Mn
Mar 31, 2015 32.28 Mn
Sep 30, 2014 37.12 Mn
Jun 30, 2014 36.34 Mn
Mar 31, 2014 36.67 Mn
Sep 30, 2013 36.97 Mn
Jun 30, 2013 34.92 Mn
Mar 31, 2013 33.29 Mn
Sep 30, 2012 32.14 Mn
Jun 30, 2012 31.65 Mn
Mar 31, 2012 31.10 Mn
Sep 30, 2011 30.38 Mn
Jun 30, 2011 29.63 Mn